Therapy (HCV)
"Interferon-Ribavirin for Chronic Hepatitis C With and Without Cirrhosis: Analysis of Individual Patient Data of Six Controlled Trials."
Published in Hepatitis Weekly, September 6th, 1999
According to the authors' abstract of an article published in Gastroenterology, "Background & Aims: The aim of this study was to compare interferon (IFN)-ribavirin combination therapy with IFN monotherapy in chronic hepatitis C with particular focus on its efficacy in cirrhosis. Methods: A multivariate analysis of individual patient data of all randomized controlled trials using an IFN-ribavirin arm, reported between 1991 and March 1998, was performed. Centers included 1 Asian and 5 European university-based referral centers for liver disease. A total of 197 patients with chronic hepatitis C received IFN-alpha (3 MU three times weekly) and ribavirin (1-1.2 g daily) for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-09-06)
More Articles from Hepatitis Weekly
- Interferon Therapy (HBV)
Lengthened IFN Therapy Improves HBV Outcome - Coinfection (HCV/HBV)
HCV Infection Alters HBV Progression - Disease Associations
HBV Infection Could Be Linked to Aplastic Anemia - Epidemiology (TTV/HCV)
TTV Incidence Independent of HCV in Japan - Interferon Therapy (HCV)
IFN-(beta) May Be Wrong Choice in HCV with Myasthenia Gravis - Interferon Therapy (HCV)
Serum Gamma-GT/ALT May Show IFN Response - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
